Sehn, Laurie H <br/><br/>
Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity.  [electronic resource] 

 -  Blood  Jan 2015 
 - 22-32 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2014-05-577189  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Murine-Derived--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>B-Lymphocytes--cytology<br/>Biomarkers, Tumor--metabolism<br/>Clinical Trials as Topic<br/>Cyclophosphamide--therapeutic use<br/>Doxorubicin--therapeutic use<br/>Female<br/>Gene Expression Profiling<br/>Humans<br/>Lymphoma, Large B-Cell, Diffuse--therapy<br/>Male<br/>Prednisone--therapeutic use<br/>Prognosis<br/>Rituximab<br/>Salvage Therapy--methods<br/>Time Factors<br/>Treatment Outcome<br/>Vincristine--therapeutic use